Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikofen injection for acute postoperative pain after laparoscopic gynecological surgery
ChiCTR2600117976Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine in postoperative pain (4 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Area under the time curve of resting NRS score within 8 hours of investigational drug. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600117976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117976.